Cargando…
Isolated prostate amyloidosis; a case report
Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508406/ https://www.ncbi.nlm.nih.gov/pubmed/36164377 http://dx.doi.org/10.1016/j.eucr.2022.102229 |
_version_ | 1784797011116032000 |
---|---|
author | Sibley, Robert R. Ellison, Benjamin Siegert, James J. Van Gorder, Mark A. |
author_facet | Sibley, Robert R. Ellison, Benjamin Siegert, James J. Van Gorder, Mark A. |
author_sort | Sibley, Robert R. |
collection | PubMed |
description | Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old male presenting from his primary care provider with an elevated PSA. The patient underwent MRI-TRUS fusion biopsy of the prostate, which demonstrated AL (lambda)-type amyloidosis, confirmed by mass spectrometry in addition to prostatic adenocarcinoma. He was subsequently diagnosed with primary amyloidosis of the prostate without evidence of other amyloid deposition sites. |
format | Online Article Text |
id | pubmed-9508406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95084062022-09-25 Isolated prostate amyloidosis; a case report Sibley, Robert R. Ellison, Benjamin Siegert, James J. Van Gorder, Mark A. Urol Case Rep Oncology Identification of amyloidosis on a prostate biopsy specimen raises suspicion for systemic amyloidosis. For patients at risk of prostate adenocarcinoma, a transrectal MRI ultrasound fusion (MRI-TRUS) guided biopsy of the prostate is often needed for further investigation. Our patient is a 70 year old male presenting from his primary care provider with an elevated PSA. The patient underwent MRI-TRUS fusion biopsy of the prostate, which demonstrated AL (lambda)-type amyloidosis, confirmed by mass spectrometry in addition to prostatic adenocarcinoma. He was subsequently diagnosed with primary amyloidosis of the prostate without evidence of other amyloid deposition sites. Elsevier 2022-09-16 /pmc/articles/PMC9508406/ /pubmed/36164377 http://dx.doi.org/10.1016/j.eucr.2022.102229 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Oncology Sibley, Robert R. Ellison, Benjamin Siegert, James J. Van Gorder, Mark A. Isolated prostate amyloidosis; a case report |
title | Isolated prostate amyloidosis; a case report |
title_full | Isolated prostate amyloidosis; a case report |
title_fullStr | Isolated prostate amyloidosis; a case report |
title_full_unstemmed | Isolated prostate amyloidosis; a case report |
title_short | Isolated prostate amyloidosis; a case report |
title_sort | isolated prostate amyloidosis; a case report |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508406/ https://www.ncbi.nlm.nih.gov/pubmed/36164377 http://dx.doi.org/10.1016/j.eucr.2022.102229 |
work_keys_str_mv | AT sibleyrobertr isolatedprostateamyloidosisacasereport AT ellisonbenjamin isolatedprostateamyloidosisacasereport AT siegertjamesj isolatedprostateamyloidosisacasereport AT vangordermarka isolatedprostateamyloidosisacasereport |